Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 456

1.

Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells.

Park SJ, Lee KP, Kang S, Chung HY, Bae YS, Okajima F, Im DS.

Cell Signal. 2013 Nov;25(11):2147-54. doi: 10.1016/j.cellsig.2013.07.001. Epub 2013 Jul 6.

PMID:
23838008
2.

Lysophosphatidylethanolamine increases intracellular Ca(2+) through LPA(1) in PC-12 neuronal cells.

Lee JM, Park SJ, Im DS.

Biochem Biophys Res Commun. 2015 May 29;461(2):378-82. doi: 10.1016/j.bbrc.2015.04.042. Epub 2015 Apr 16.

PMID:
25888792
3.

Action and Signaling of Lysophosphatidylethanolamine in MDA-MB-231 Breast Cancer Cells.

Park SJ, Lee KP, Im DS.

Biomol Ther (Seoul). 2014 Feb;22(2):129-35. doi: 10.4062/biomolther.2013.110.

4.

Lysophosphatidylserine induces calcium signaling through Ki16425/VPC32183-sensitive GPCR in bone marrow-derived mast cells and in C6 glioma and colon cancer cells.

Kim K, Kim HL, Lee YK, Han M, Sacket SJ, Jo JY, Kim YL, Im DS.

Arch Pharm Res. 2008 Mar;31(3):310-7. doi: 10.1007/s12272-001-1157-x. Epub 2008 Apr 13.

PMID:
18409043
5.
6.

LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells.

Chen M, Towers LN, O'Connor KL.

Am J Physiol Cell Physiol. 2007 May;292(5):C1927-33.

7.

Calcium Signaling of Lysophosphatidylethanolamine through LPA1 in Human SH-SY5Y Neuroblastoma Cells.

Lee JM, Park SJ, Im DS.

Biomol Ther (Seoul). 2017 Mar 1;25(2):194-201. doi: 10.4062/biomolther.2016.046.

8.

Dioleoyl phosphatidic acid increases intracellular Ca2+ through endogenous LPA receptors in C6 glioma and L2071 fibroblasts.

Chang YJ, Kim YL, Lee YK, Sacket SJ, Kim K, Kim HL, Han M, Bae YS, Okajima F, Im DS.

Prostaglandins Other Lipid Mediat. 2007 Jun;83(4):268-76. Epub 2007 Feb 3.

PMID:
17499746
9.

Lysophosphatidic acid-stimulated interleukin-6 and -8 synthesis through LPA1 receptors on human osteoblasts.

Aki Y, Kondo A, Nakamura H, Togari A.

Arch Oral Biol. 2008 Mar;53(3):207-13. Epub 2007 Oct 29.

PMID:
17915188
10.

LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites.

Komachi M, Tomura H, Malchinkhuu E, Tobo M, Mogi C, Yamada T, Kimura T, Kuwabara A, Ohta H, Im DS, Kurose H, Takeyoshi I, Sato K, Okajima F.

Carcinogenesis. 2009 Mar;30(3):457-65. doi: 10.1093/carcin/bgp011. Epub 2009 Jan 7.

PMID:
19129242
11.

Gintonin, newly identified compounds from ginseng, is novel lysophosphatidic acids-protein complexes and activates G protein-coupled lysophosphatidic acid receptors with high affinity.

Hwang SH, Shin TJ, Choi SH, Cho HJ, Lee BH, Pyo MK, Lee JH, Kang J, Kim HJ, Park CW, Shin HC, Nah SY.

Mol Cells. 2012 Feb;33(2):151-62. doi: 10.1007/s10059-012-2216-z.

12.

Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid.

Bandoh K, Aoki J, Hosono H, Kobayashi S, Kobayashi T, Murakami-Murofushi K, Tsujimoto M, Arai H, Inoue K.

J Biol Chem. 1999 Sep 24;274(39):27776-85.

13.

Identification of heparin-binding EGF-like growth factor (HB-EGF) as a biomarker for lysophosphatidic acid receptor type 1 (LPA1) activation in human breast and prostate cancers.

David M, Sahay D, Mege F, Descotes F, Leblanc R, Ribeiro J, Cl├ęzardin P, Peyruchaud O.

PLoS One. 2014 May 14;9(5):e97771. doi: 10.1371/journal.pone.0097771. eCollection 2014.

14.

Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors.

Ohta H, Sato K, Murata N, Damirin A, Malchinkhuu E, Kon J, Kimura T, Tobo M, Yamazaki Y, Watanabe T, Yagi M, Sato M, Suzuki R, Murooka H, Sakai T, Nishitoba T, Im DS, Nochi H, Tamoto K, Tomura H, Okajima F.

Mol Pharmacol. 2003 Oct;64(4):994-1005.

15.
16.

Lysophosphatidylserine stimulates L2071 mouse fibroblast chemotactic migration via a process involving pertussis toxin-sensitive trimeric G-proteins.

Park KS, Lee HY, Kim MK, Shin EH, Jo SH, Kim SD, Im DS, Bae YS.

Mol Pharmacol. 2006 Mar;69(3):1066-73. Epub 2005 Dec 20.

17.

Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1.

Yamada T, Sato K, Komachi M, Malchinkhuu E, Tobo M, Kimura T, Kuwabara A, Yanagita Y, Ikeya T, Tanahashi Y, Ogawa T, Ohwada S, Morishita Y, Ohta H, Im DS, Tamoto K, Tomura H, Okajima F.

J Biol Chem. 2004 Feb 20;279(8):6595-605. Epub 2003 Dec 3.

18.
19.
20.

Dioleoyl phosphatidic acid induces morphological changes through an endogenous LPA receptor in C6 glioma cells.

Chang YJ, Kim YL, Jo JY, Kyeok K, Kim HL, Im DS.

Arch Pharm Res. 2008 May;31(5):628-33. doi: 10.1007/s12272-001-1204-7. Epub 2008 May 15.

PMID:
18481020

Supplemental Content

Support Center